Key facts
- This page summarizes Robert Janssen's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 16:43.
Robert Janssen - 15 Feb 2024 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)
- Reporting relationship
- SVP and CMO
- Issuer ticker
- DVAX
- Reported as of
- 15 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 16:43:41 UTC
- Prior SEC filing
- 13 Feb 2024
- Next SEC filing
- 12 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ ROBERT JANSSEN
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Janssen filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 13 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DVAX
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $12.48
- Footnotes
- F1, F2
DVAX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- Shares
- +35,710
- Change %
- Price
- Shares after
- 35,710
- Date
- 15 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,710
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Code A: Grant, award or other acquisition
Footnote F2
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Footnote F3
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.